Ranbaxy Q1 net down 48 per cent to Rs 101.3 cr

Ranbaxy Laboratories reported 48% dip in net profit to Rs 101.3 crore for the quarter ended June 2005.

India's largest drug-maker, Ranbaxy Laboratories, on Thursday reported 48 per cent dip in net profit (and minority interest) to Rs 101.3 crore for the quarter ended June 2005 as against Rs 195.8 crore for the same period last year.

HT Image

Consolidated sales of the company during the first quarter this fiscal grew 7 per cent to Rs 1347.9 crore as compared to Rs 1258.0 crore in the year-ago period, company officials said.